Related Experiment Video
Updated: Mar 8, 2026
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
The Human Stomach in Health and Disease: Infection Strategies by Helicobacter pylori
Karen Robinson1, Darren P Letley2, Kazuyo Kaneko2
1NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the Nottingham Digestive Diseases Centre, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK. Karen.robinson@nottingham.ac.uk.
Insights
Helicobacter pylori infection is common and usually asymptomatic, but can lead to peptic ulcers and gastric cancer in some individuals. Further research is needed to understand the factors influencing disease development.
Area of Science:
- Gastroenterology
- Microbiology
- Oncology
Background:
- Helicobacter pylori is a widespread bacterial pathogen colonizing the human stomach.
- While often asymptomatic, H. pylori infection is a primary risk factor for peptic ulcer disease and gastric cancer.
- Gastric adenocarcinoma is a leading cause of cancer mortality, and peptic ulcers contribute significantly to morbidity.
Purpose of the Study:
- To summarize current knowledge on health and disease outcomes associated with H. pylori infection.
- To identify key bacterial, host, and environmental factors influencing H. pylori-related diseases.
- To highlight areas requiring further scientific investigation.
Main Methods:
- Literature review and synthesis of existing research on H. pylori.
- Analysis of factors contributing to chronic inflammation and gastric mucosa damage.
- Examination of the interplay between bacterial, host, and environmental elements.
Main Results:
- H. pylori infection is a major etiological agent for peptic ulcer disease and gastric cancer.
- Disease development occurs in 10-15% of infected individuals, influenced by multiple factors.
- Chronic inflammation and mucosal damage are central to disease pathogenesis.
Conclusions:
- Understanding H. pylori's role in gastric diseases is crucial for public health.
- The complex interplay of factors necessitates continued research for effective prevention and treatment strategies.
- Further studies are essential to elucidate mechanisms driving H. pylori-associated morbidity and mortality.
Abstract:
Helicobacter pylori is a bacterial pathogen which commonly colonizes the human gastric mucosa from early childhood and persists throughout life. In the vast majority of cases, the infection is asymptomatic. H. pylori is the leading cause of peptic ulcer disease and gastric cancer, however, and these outcomes occur in 10-15% of those infected. Gastric adenocarcinoma is the third most common cause of cancer-associated death, and peptic ulcer disease is a significant cause of morbidity. Disease risk is related to the interplay of numerous bacterial host and environmental factors, many of which influence chronic inflammation and damage to the gastric mucosa. This chapter summarizes what is known about health and disease in H. pylori infection, and highlights the need for additional research in this area.
More Related Videos
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease